Progestogen only contraception in women with congenital heart disease
Background There is little information of progestogen-only contraceptives in patients with congenital heart disease (CHD) on the long-term.Objective To evaluate the use of contraception in patients with CHD. We studied both short-acting reversible contraceptives (SARCs), oral progestin-only pills (P...
Saved in:
Main Authors: | Francesc Baró-Mariné, Antonia Pijuan-Domènech, Maria del Mar Goya, Elena Suárez-Edo, Berta Miranda-Barrio, Laura Dos-Subirà, Maria Luisa Pancorbo, Ignacio Ferreira-Gonzalez, Elena Carreras-Moratonas |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Obstetrics and Gynaecology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/01443615.2024.2320296 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease
by: Brittany Huynh, et al.
Published: (2025-01-01) -
Geographic distribution and demographic factors associated with use of a long-acting reversible contraceptive (LARC) in Ethiopia
by: Mintesnot Tenkir Teni, et al.
Published: (2025-01-01) -
A review of various types of male contraception
by: Yeonhee Pyo, et al.
Published: (2024-12-01) -
Knowledge, attitude and acceptability for long-acting reversible contraceptive (LARC) methods among women attending contraception counselling sessions: A cross-sectional study
by: Paridhi Gupta, et al.
Published: (2025-01-01) -
Factors that influence the choice of long-acting reversible contraceptive use among adolescents post-abortion in Chongqing, China: a cross-sectional study
by: Fengzhen Jin, et al.
Published: (2024-12-01)